Moreover, Notch1 inhibitor treatment blocked the protective effect of USP10 in CFs injury, suggesting that Notch1, as a downstream key molecule of USP10, was involved in the protective effect exerted by FSTL1 on MI in T2DM. This evidence concerns the gene FSTL1 and type 2 diabetes mellitus.